Hey, Texas, just let adults decide if, when and how to use cannabis – San Antonio Express-News
#65 Notable Clinical Interest
Emerging findings or policy developments worth monitoring closely.
# Clinical Summary This opinion piece advocates for adult autonomy in cannabis decision-making rather than continued legal restrictions in Texas, reflecting broader policy debates that increasingly emphasize personal choice over prohibition. The argument aligns with evolving public health perspectives recognizing that criminalization has failed to prevent use while creating collateral social harms, and that regulatory frameworks allowing legal access may better serve public health than prohibition. For clinicians, this policy perspective is relevant because legal status directly impacts patient disclosure patterns, access to consistent products, and the ability to conduct robust clinical research on cannabis therapeutics. States that have legalized cannabis have generally seen improved patient-clinician communication about use, better documentation of outcomes, and expanded opportunities for studying cannabis safety and efficacy in clinical populations. Practically, clinicians should remain attuned to changing state-level policy landscapes, as legalization may increase patient willingness to discuss cannabis use in clinical encounters and could eventually enable more evidence-based prescribing guidance.
“What we’ve learned from two decades of cannabis prohibition is that law enforcement approaches don’t change patient behavior, they just change who profits and who faces criminal consequences, so the evidence now clearly supports letting adults make their own decisions with accurate information rather than arbitrary restrictions that prevent us as physicians from having honest conversations about risk and benefit.”
? While policy arguments for cannabis liberalization often center on personal autonomy and reducing incarceration, clinicians should recognize that individual decision-making capacity regarding cannabis use is shaped by incomplete information, variable risk perception, and neurobiological vulnerabilities that differ across patients. The framing of cannabis as purely a matter of personal choice obscures important clinical realities: adolescents and young adults face documented risks to brain development, pregnant patients face potential fetal effects still being characterized, and individuals with personal or family histories of psychosis may have substantially elevated risks that they may not fully appreciate. Rather than positioning cannabis regulation as an all-or-nothing choice between prohibition and unfettered access, healthcare providers should prepare to engage patients in nuanced shared decision-making that acknowledges legitimate autonomy while grounding conversations in personalized risk assessment based on age, medical history, pregnancy status, and psychiatric vulnerability. The clinical implication is that providers need evidence-based frameworks for
This topic comes up in consultations often.
Dr. Caplan offers clinical context on evolving cannabis policy and its real-world implications for patients.
Book a consultation →💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
